Recent advances in Ndds (novel drug delivery system) for delivery of anti-hypertensive drugs

International Journal of Drug Development and Research

Volumn 3, Issue 1, 2011, Pages 252-259

  Vikas, Kumar ^a   Arvind, Sharma ^a   Ashish, Sharma ^b   Gourav, Joshi ^b   Vipasha, Dhillon ^a  

^a CHITKARA UNIVERSITY   (India)

^b Rayat Institute of Pharmacy   (India)

Author keywords

Emulsomes; Hypertension; Liposomes; Microemulsions; Nanoparticles

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; LACIDIPINE; LIPOSOME; LOSARTAN; METOPROLOL TARTRATE; NANOPARTICLE; NITRENDIPINE; PROPRANOLOL; UBIDECARENONE; VASODILATOR AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CERAMICS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUBILITY; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; PERMEABILITY; SUSTAINED RELEASE FORMULATION;

EID: 79955906703     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gates KA et al. Pharm Res 1994; 11: 1605-1609.
2. Banaker UV. Am Pharm 1987; 2: 39-48.
3. Kamath KR, Park K. Mucosal adhesive preparations. Boylan (Eds.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, 1994, 133-163.
4. Li X.L, Chan WK. Adv Drug Deliv Rev 1999; 39: 81-103.
5. Formulation and Evaluation of Hydrogel Based Oral Controlled Drug Delivery System for Antihypertensive Drug, Pavithra T.K, Harshitha R, Panneer K, Renuka S, Prakash Rao B, Narendra C
6. T. Higuchi. Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm.Sci 52: 1145-9 (1963).
7. P. I. Lee. Novel zero order drug delivery via immobilized nonuniformed drug distribution in glassy hydrogels, J. Pharm. Sci 73: 1344-7 (1984).
8. E. Rinaki, G. Valsami, and P. Macheras. The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis, Int. J. Pharm 255 (1-2): 199-207 (2004).
9. V. Pillay, R. Fassihi, A novel approach for constant rate delivery of highly soluble bioactives from a simple monolithic system, J. Controlled Release 67 (2000) 67-78.
10. P. Benfield, S.P. Clissold, R.N. Brogden, Metoprolol: an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders, Drugs 31 (1986) 376-429.
11. Y.S.R. Krishnaiah, R.S. Karthikeyan, V. Satyanarayana, A threelayer guar gum matrix tablet formulations for oral controlled delivery of highly soluble metoprolol tartrate, Int. J. Pharm. 241 (2002) 353-366.
12. Panyam J, Labhasetwar V. Adv Drug Deliv Rev 2003; 55: 329-347.
13. L Brannon-Peppas, JO Blanchette. Adv Drug Deliv Rev 2004; 56: 1649-1659.
14. F De Jaeghere, E Allemann, F Kubel, B Galli, R Cozens, E Doelker, R Gurny. J Control Release 2000; 68: 291-298.
15. Preparation and stabilization of nifedipine lipid nanoparticles. Seitaro Kamiyaa, Mariko Yamadaa, Takurou Kurita, Atsuo Miyagishima, Masayuki Arakawa, Takashi Sonobe.
16. S. Hariharan, V. Bhardwaj, I. Bala, J. Sitterberg, U. Bakowasky, M.N.V.R. Kumar, Design of estradiol loaded PLGA nanopaticles formulations: a potential oral delivery system for hormone therapy, Pharm. Res. 23 (2006) 184-189
17. I. Bala, V. Bhardwaj, S. Hariharan, S.V. Karade, N. Roy, M.N.V.R. Kumar, Sustained release nanoparticulate formulation containing antioxidant ellagic acid as potential prophylaxis system for oral administration, J. Drug. Target. 14 (2006) 27-34.
18. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: Formulation optimization, ex vivo and in vivo characterization, Ramesh Gannu, Chinna Reddy Palem, Vamshi Vishnu Yamsani, Shravan Kumar Yamsani, Madhusudan Rao Yamsani.
19. Kreilgaard, M., Pedersen, E.J., Jaroszewski, J.W., 2000. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J. Control Release 69, 421-433
20. Vyas SP, Khar RK. Targeted and controlled drug delivery, 2004; 1:417-425.
21. Formulation Design, Preparation of Losartan Potassium Microspheres by Solvent Evaporation Method and It's In Vitro Characterization Rout Prasant kumar and Nayak Bhabani Shankar
22. Bhumkar D.R., Maheshwari M, Patil V.B., Pokharkar V.B; Indian Drugs, 2006; 40(8), 455-461.
23. Shovarani K.N., Goundalkar A.G; Indian Journal. Pharm. Sciences, 1994; 56(4), 45-50.
24. Ghosh A., Nayak U.K., Roy P; The International Journal. Pharmacy, 2007; 6, 84-89.
25. Gohel M.C., Parik R.K., Amin A.F., Surati A.K; Indian Journal. Pharm Sci., 2005; 67(8), 575-581.